🟢 Eupraxia Pharmaceuticals is trading 12.2% up today following leadership and operations updates

Eupraxia Pharmaceuticals is trading 12.2% up at $7.00 in pre-market, rebounding from recent weakness and moving back above last week’s range.

• The move follows July updates regarding executive hires, a board refresh, and the relocation of operations to Vancouver and Seattle.
• Management highlighted strong liquidity and upcoming RESOLVE trial milestones, supported by a broader rise in equity futures.